-transparent.png){kind=logo}
Human leukemia U-937 cell sublines exhibiting various levels of resistance to 9-nitrocamptothecin (9NC) were developed after exposure to progressively increased 9NC concentrations. Increases in 9NC resistance of the cells were accompanied by decreases in proliferation rate; appearance of morphological and functional features that correlate with granulocytic maturation; decreased synthesis of topoisomerase I; increased synthesis of topoisomerase II; and inability or decreased ability to induce tumors when xenografted in nude mice. 9NC-resistant cells, transferred and propagated in 9NC-free media for 6 months, continue to exhibit resistance and other features similar to cells propagated in continual presence of 9NC. Finally, 9NC-resistant U-937 cells respond to physiological and non-physiological agents of cell differentiation, indicating that alternative treatments can be successfully used to inhibit growth of 9NC-resistant U-937 cells and tumors.
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
January 1995,
Anticancer research,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
February 1998,
Journal of hematotherapy,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
May 1976,
International journal of cancer,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
January 1994,
Anticancer research,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
January 1996,
Leukemia research,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
January 1988,
The International journal of biochemistry,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
August 1988,
Journal of immunology (Baltimore, Md. : 1950),
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
April 1990,
Leukemia,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
November 2006,
Ai zheng = Aizheng = Chinese journal of cancer,
P Pantazis, and
J T Mendoza, and
A DeJesus, and
E Rubin, and
D Kufe, and
B C Giovanella
February 1999,
AIDS research and human retroviruses,
